• Accueil
• caseum
• A Novel Tool to Identify Bactericidal Compounds against Vulnerable Targets in Drug-Tolerant M. tuberculosis found in Caseum

A Novel Tool to Identify Bactericidal Compounds against Vulnerable Targets in Drug-Tolerant M. tuberculosis found in Caseum

4.8 (774) · € 24.99 · En Stock

Revolutionizing control strategies against Mycobacterium tuberculosis infection through selected targeting of lipid metabolism

Drug discovery in tuberculosis. New drug targets and antimycobacterial agents - ScienceDirect

Bioprospecting for antituberculosis natural products – A review

Inhibiting Mycobacterium tuberculosis DosRST Signaling by Targeting Response Regulator DNA Binding and Sensor Kinase Heme

The Expanding Diversity of Mycobacterium tuberculosis Drug Targets

Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in Mycobacterium tuberculosis Infected C3HeB/FeJ Mice

The quest for the holy grail: new antitubercular chemical entities, targets and strategies - ScienceDirect

IJMS, Free Full-Text

Distribution of PK/PD target attainment per drug. Exposure of 1,000

Anti-tuberculosis treatment strategies and drug development: challenges and priorities

ADP-ribosylation-resistant rifabutin analogs show improved bactericidal activity against drug-tolerant M. abscessus in caseum surrogate

Identification of Novel, Potent, and Selective Compounds against Malaria Using Glideosomal-Associated Protein 50 as a Drug Target

Prediction of Drug Penetration in Tuberculosis Lesions.

PDF) A Novel Tool to Identify Bactericidal Compounds against Vulnerable Targets in Drug-Tolerant M. tuberculosis found in Caseum

TBAJ-587 (S) is more active than bedaquiline (B) either alone or in